Financhill
Sell
36

SMMT Quote, Financials, Valuation and Earnings

Last price:
$17.86
Seasonality move :
15.86%
Day range:
$17.17 - $18.31
52-week range:
$2.10 - $33.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13,242.96x
P/B ratio:
30.05x
Volume:
2.2M
Avg. volume:
2M
1-year change:
583.72%
Market cap:
$13.2B
Revenue:
--
EPS (TTM):
-$0.24

Earnings Data

Next earnings date for SMMT
Feb 20
2025
Most recent earnings per share
-$0.08
Missed by $0.01
(Oct 30/2024)
Consensus Estimate
-$0.07
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SMMT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.08 --
02/20/2025 Q4 -- -- -- -$0.08 --
10/30/2024 Q3 -- -- -$0.08 -$0.07 -$0.01
08/06/2024 Q2 -- -- -$0.09 -$0.06 -$0.03
05/01/2024 Q1 -- -- -$0.06 -$0.06 -$0.00
02/20/2024 Q4 -- -- -$0.01 -- --
11/07/2023 Q3 -- -- -$0.03 -- --
08/09/2023 Q2 -- -- -$0.02 -- --
05/11/2023 Q1 -- -- -$1.43 -- --
03/09/2023 Q4 -- -- -$0.04 -- --
11/09/2022 Q3 -- -- -$0.14 -- --
08/11/2022 Q2 -- -- -$0.17 -- --
05/11/2022 Q1 -- -- -$0.22 -- --
03/17/2022 Q4 -- -- -$0.28 -- --
11/15/2021 Q3 -- -- -$0.20 -$0.29 $0.09
08/11/2021 Q2 -- -- -$0.27 -$0.18 -$0.09
05/17/2021 Q1 -- -- -$0.21 -$0.17 -$0.04
12/31/2020 Q4 -- -- -$0.18 -$0.21 $0.03
11/16/2020 Q3 -- -- -$0.26 -$0.24 -$0.02
06/30/2020 Q2 -- -- -- -$0.08 --
03/31/2020 Q1 -- -- -$0.01 -$0.02 $0.01
03/27/2020 Q1 -- -- -- -$0.40 --
03/27/2020 Q4 -- -- -- -$0.03 --
12/17/2019 Q4 -- -- -$0.05 -- --
10/11/2019 Q3 -- -- -$0.18 -$0.56 $0.38
06/12/2019 Q2 -- -- -$0.19 -$0.26 $0.06
03/27/2019 Q1 -- -- -$0.33 -- --
12/11/2018 Q4 -- -- -$0.63 -$0.15 -$0.47
09/14/2018 Q3 -- -- $2.43 -$0.39 $2.82
06/05/2018 Q2 -- -- -$0.53 -$0.14 -$0.40
04/11/2018 Q1 -- -- -$1.14 -$0.12 -$1.01
12/06/2017 Q4 -- -- -$0.20 -$0.13 -$0.07
08/31/2017 Q3 -- -- $1.09 $0.32 $0.77
06/14/2017 Q2 -- -- -$0.51 -- --
03/29/2017 Q1 -- -- -$0.50 -- --

Summit Therapeutics Earnings Questions

  • How Much did Summit Therapeutics Generate in Revenue Last Quarter?

    Summit Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Summit Therapeutics Beat Earnings Last Quarter?

    Summit Therapeutics announced earnings per share of -$0.08 which represents a miss of analyst forecast a -$0.07 per share.

  • Is Summit Therapeutics Profitable?

    Summit Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Summit Therapeutics EPS Next Year?

    Summit Therapeutics's earnings are forecast to decrease from -$0.99 per share to -$0.30 per share next year representing a decrease of -69.42%.

  • When is Summit Therapeutics's Earnings Date?

    Summit Therapeutics's next earnings date is February 20, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Adobe Stock Dropping?
Why Is Adobe Stock Dropping?

Why is Adobe stock dropping? A combination of underwhelming fiscal…

Why Is 3M Stock Going Up?
Why Is 3M Stock Going Up?

After a decade-long slump in new product introductions, the leading…

Is It Time for Costco to Split?
Is It Time for Costco to Split?

Costco’s stock price has experienced enormous growth over the last…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 41x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
77
FTAI alert for Jan 1

FTAI Aviation [FTAI] is up 13.87% over the past day.

Buy
56
QMCO alert for Jan 1

Quantum [QMCO] is down 13.43% over the past day.

Buy
60
ARQQ alert for Jan 1

Arqit Quantum [ARQQ] is down 10.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock